Meiling Ji
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 22
- Colorectal Cancer Treatments and Studies 15
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Surgical Treatments 3
-
- Genetic factors in colorectal cancer 7
- Co-authors
- Guodong He (20 shared papers)Jianmin Xu (18 shared papers)Ye Wei (22 shared papers)Wenju Chang (20 shared papers)Dexiang Zhu (21 shared papers)Li Ren (16 shared papers)Qingyang Feng (17 shared papers)Wentao Tang (14 shared papers)
- Journals
- Cancer Management and Research (3 papers)Annals of Surgical Oncology (2 papers)Frontiers in Oncology (2 papers)OncoTargets and Therapy (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Meiling Ji
37 papers receiving 1k citations
Peers
Comparison fields: 5 of 76
- Oncology 290
- Cancer Research 124
- Immunology 139
- Molecular Biology 321
- Pulmonary and Respiratory Medicine 132
Countries citing papers authored by Meiling Ji
This map shows the geographic impact of Meiling Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Ji more than expected).
Fields of papers citing papers by Meiling Ji
This network shows the impact of papers produced by Meiling Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Ji. The network helps show where Meiling Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 140 | |
| 2 | 2019 | 114 | |
| 3 | 2018 | 93 | |
| 4 | 2020 | 68 | |
| 5 | 2018 | 62 | |
| 6 | 2022 | 55 | |
| 7 | 2023 | 54 | |
| 8 | 2022 | 52 | |
| 9 | 2016 | 32 | |
| 10 | 2016 | 28 | |
| 11 | 2022 | 28 | |
| 12 | 2018 | 26 | |
| 13 | 2019 | 20 | |
| 14 | CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer. | 2019 | 20 |
| 15 | 2015 | 18 | |
| 16 | 2016 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2022 | 17 | |
| 19 | 2017 | 16 | |
| 20 | 2019 | 15 |
About Meiling Ji
Meiling Ji is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Immunology, having authored 37 papers that have together received 1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (7 papers), Mechanisms of cancer metastasis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Surgical Treatments (3 papers), Ferroptosis and cancer prognosis (3 papers), Immune cells in cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (290 citations), Cancer Research (124 citations), Immunology (139 citations), Molecular Biology (321 citations) and Pulmonary and Respiratory Medicine (132 citations). Meiling Ji has collaborated with scholars based in China and United States. Frequent co-authors include Guodong He, Jianmin Xu, Ye Wei, Wenju Chang, Dexiang Zhu, Li Ren, Qingyang Feng, Wentao Tang, Liangliang Yang and Yihao Mao. Their work appears in journals such as Cancer Management and Research, Annals of Surgical Oncology, Frontiers in Oncology, OncoTargets and Therapy and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.